•
Dec 31, 2018

Denali Therapeutics Q4 2018 Earnings Report

Total Revenue
$126M
Previous year: $145M
-13.4%
EPS
$0.79
Previous year: -$0.74
-206.8%
Gross Profit
$85.8M
Previous year: $127M
-32.3%
Cash and Equivalents
$77.1M
Free Cash Flow
$91.7M
Total Assets
$662M

Denali Therapeutics

Denali Therapeutics